The Many Facets of Pharmacovigilance
More than Just Paper Shuffling and Regulations
Dr. Yvonne Nanciu, Country Head Pharmacovigilance Germany at Bayer Pharmaceuticals, joined the Safety Signals Podcast to explain how pharmacovigilance can be a rich and rewarding field. The lively discussion covered a far-reaching variety of topics, including:
- The importance of having practitioners with diverse backgrounds
- The need for predictive analytics
- Ways to improve patient centricity
Dr. Nanciu, who also lectures on pharmacovigilance at universities throughout Germany, tells her students that “pharmacovigilance is like medicine on paper. So you have your patients, you have their adverse event reports, you have their entire history, diagnostic, lab values, disease, evolution, and you can see their evolution through a disease.”
The views of the hosts and guests featured on Safety Signals are their own and do not necessarily reflect the views of Saama or the individual companies for which the guests may work.
About Saama Safety Signals
Introducing Safety Signals, the show for pharmacovigilance professionals, benefit risk managers, epidemiologists, and other patient safety stakeholders. From pharma leaders to academics and scientists, we provide expert perspectives on the challenges, opportunities, and technologies that are shaping the future of the safety sciences. Get ready to be inspired and energized as you work to reduce the risk of life-changing–and life SAVING–medical treatments.
Meet Your Hosts & Guests
Vice President & Partner
Country Head Pharmacovigilance Germany at Bayer Pharmaceuticals